Understanding Clinical Trials
Clinical trials are carefully designed research studies that help researchers evaluate new treatments, medications, and approaches to managing myasthenia gravis (MG). They are an essential part of medical research, providing evidence about the safety and effectiveness of potential therapies before they become widely available to patients.
Researchers rely on volunteers to help advance the understanding of MG and improve future treatment options. By participating in clinical trials, individuals contribute to research that may lead to better therapies, improved quality of life, and more effective care for people living with myasthenia gravis now and in the future.
Key Impact Areas
Clinical trials help advance research into myasthenia gravis and may contribute to the development of future treatments, improved care, and a better understanding of the condition.
Here are some of the potential benefits of participating in a clinical trial:
Access to Emerging Treatments
- Clinical trials may provide access to new therapies before they become widely available.
Support Medical Research
- Help researchers improve the understanding and treatment of myasthenia gravis.
Contribute to Future Care
- Your participation may benefit future generations living with MG.
Advance Knowledge
- Clinical trials help identify safer and more effective treatment options.
Stay Informed About New Clinical Trials
Receive Updates on Clinical Trials and Research
Be part of the movement to raise awareness, support advocacy, and drive research for Myasthenia Gravis. Register for the MAA News Feed and receive updates on events, fundraising opportunities, and ways to contribute.
CURRENT MYASTHENIA GRAVIS CLINICAL TRIALS
Myasthenia Alliance Australia is committed to helping the Australian MG community stay informed about current clinical trials and research opportunities. The studies listed below may involve emerging treatments, new approaches to care, or research designed to improve our understanding of myasthenia gravis.
Clinical trial opportunities are updated as information becomes available. Click on any study below to learn more about eligibility requirements, locations, and participation details.
Browse the latest clinical trial opportunities below.
MAA proudly supporting MGBase
The MGBase Registry is the first global, observational registry dedicated to evaluating outcomes data in myasthenia gravis. ‘MGBase’ was launched in December 2021, addressing a critical gap in the collection of ‘real-world’ patient data for this rare disease. Owned and operated by the MSBase Foundation, the MGBase Registry is built on the same robust governance and IT infrastructure that underpins the highly successful MSBase Registry for multiple sclerosis.
MGBase is developed for clinicians and provides them with access to a comprehensive data entry tool and an online research platform, paving the way for collaborative, international myasthenia research that aims to enhance the quality of care and improve patient outcomes. Membership is free and open to all practising neurologists treating patients with Myasthenia.
As at February 2025, the international registry contained over 1050 patients and is growing daily. Over half of the total patient cohort is being contributed by Australian MGBase centres in Victoria, Western Australia, NSW, QLD and Tasmania. 154 members (Specialists) are engaged across 12 countries and 24 clinics. The data is already contributing to research projects.
Patient registries such as MGBase are powerful instruments for expanding our knowledge of diseases. They are particularly useful in rare diseases, such as Myasthenia, where they can provide the opportunity to pool ‘real world’ data to reach a sufficient sample size for epidemiological and clinical research. If you’re interested in having your clinical data contributed, please speak to your specialist about signing up to MGBase. A dedicated membership and IT team is available to support MGBase members. Visit the website for more information www.mgbase.org, or clinicians can contact info@mgbase.org directly for more information on how to join.